Mira A Patel
Overview
Explore the profile of Mira A Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al.
J Immunother Cancer
. 2016 May;
4:28.
PMID: 27190629
Background: Glioblastoma (GBM) is a poorly immunogenic neoplasm treated with focused radiation. Immunotherapy has demonstrated synergistic survival effects with stereotactic radiosurgery (SRS) in murine GBM. GITR is a co-stimulatory molecule...
12.
13.
Patel M, Blackford A, Rettig E, Richmon J, Eisele D, Fakhry C
Cancer
. 2016 Mar;
122(9):1380-7.
PMID: 26950886
Background: The incidence of oropharyngeal cancer (OPC) and a subset of oral cavity cancer (OCC) is increasing in the United States. To the authors' knowledge, the presumed growing prevalence of...
14.
Liu A, Sankey E, Jusue-Torres I, Patel M, Elder B, Goodwin C, et al.
Clin Neurol Neurosurg
. 2016 Feb;
143:34-8.
PMID: 26895207
Introduction: Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder that classically presents with a triad of progressive gait impairment, urinary incontinence, and cognitive deterioration. Treatment predominantly involves ventriculoperitoneal (VP)...
15.
Kim E, Kim J, Patel M, Mangraviti A, Ruzevick J, Lim M
J Immunol Res
. 2016 Feb;
2016:4683607.
PMID: 26881264
Immune checkpoints have come to the forefront of cancer therapies as a powerful and promising strategy to stimulate antitumor T cell activity. Results from recent preclinical and clinical studies demonstrate...
16.
Patel M, Pardoll D
J Neurooncol
. 2015 Jun;
123(3):323-30.
PMID: 26070552
Immunotherapy is coming to the fore as a viable anti-cancer treatment modality, even in poorly immunogenic cancers such as glioblastoma (GBM). Accumulating evidence suggests that the central nervous system may...
17.
Patel M, Kim J, Ruzevick J, Li G, Lim M
Cancers (Basel)
. 2014 Oct;
6(4):1953-85.
PMID: 25268164
The current standard of care for glioblastoma (GBM) is maximal surgical resection with adjuvant radiotherapy and temozolomide (TMZ). As the 5-year survival with GBM remains at a dismal <10%, novel...
18.
Patel M, Caplan J, Yang W, Colby G, Coon A, Tamargo R, et al.
J Clin Neurosci
. 2014 Aug;
21(12):2184-8.
PMID: 25150765
Fenestrations of intracranial arteries and associated aneurysms are rare. The significance of these fenestrations in relation to aneurysms remains unclear. We present four patients with fenestration-associated aneurysms and a comprehensive...
19.
Gettel D, Sanborn J, Patel M, de Hoog H, Liedberg B, Nallani M, et al.
J Am Chem Soc
. 2014 Jul;
136(29):10186-9.
PMID: 25003585
Substrate-mediated fusion of small polymersomes, derived from mixtures of lipids and amphiphilic block copolymers, produces hybrid, supported planar bilayers at hydrophilic surfaces, monolayers at hydrophobic surfaces, and binary monolayer/bilayer patterns...
20.
Swope V, Jameson J, McFarland K, Supp D, Miller W, McGraw D, et al.
J Invest Dermatol
. 2012 May;
132(9):2255-62.
PMID: 22572817
The melanocortin 1 receptor (MC1R), a G(s) protein-coupled receptor, has an important role in human pigmentation. We investigated the regulation of expression and activity of the MC1R in primary human...